[Associated Press]
Published Date: July 14, 2011 08:55:00 AM EDT
NEW YORK (AP) European Union regulators approved a new treatment for lupus produced by Human Genome Sciences Inc. and GlaxoSmithKline PLC, the companies said Thursday.